Glycosylation pattern and axin expression in normal and IUGR placentae

Area of Science:

• Reproductive biology
• Developmental biology
• Biochemistry

Background:

• Intrauterine growth restriction (IUGR) is a significant complication affecting fetal development.
• Placental function is crucial for normal fetal growth.
• Aberrant protein glycosylation and altered protein expression are implicated in placental pathologies.

Purpose of the Study:

• To investigate differences in protein glycosylation patterns between normal and IUGR human placentae.
• To examine the expression levels of AXIN1 protein in placentae from normal and IUGR pregnancies.
• To explore the potential role of these molecular changes in the pathophysiology of IUGR.

Main Methods:

• Analysis of 38 human placentae (17 IUGR, 21 controls) using Western blotting with specific lectins (SNA, UEA-I, PHA-E, DBA) to assess protein glycosylation.
• Immunohistochemistry was employed to determine AXIN1 protein expression and localization within placental tissues.
• Gestational age was confirmed using last menstrual period and ultrasound measurements.

Main Results:

• Significant differences in protein glycosylation patterns were observed between normal and IUGR placentae.
• Elevated expression of AXIN1 protein was detected in placentae from IUGR pregnancies, primarily localized in the syncytiotrophoblast cytoplasm and nuclei.
• These findings indicate distinct molecular profiles in placentae affected by IUGR.

Conclusions:

• Alterations in placental glycoprotein content may contribute to restricted placental growth and development.
• The increased expression of AXIN1 protein in IUGR placentae suggests the involvement of the Wnt/β-catenin signaling pathway in the pathology of placental development.
• These molecular changes offer potential targets for understanding and managing IUGR.